Stock Research for JAZZ

JAZZ

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

JAZZ Stock Chart & Research Data

The JAZZ chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the JAZZ chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


JAZZ Due diligence Resources & Stock Charts

The JAZZ stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View JAZZ Detailed Price Forecast - CNN Money CNN View JAZZ Detailed Summary - Google Finance
Yahoo View JAZZ Detailed Summary - Yahoo! Finance Zacks View JAZZ Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View JAZZ Trends & Analysis - Trade-Ideas Barrons View JAZZ Major Holders - Barrons
NASDAQ View JAZZ Call Transcripts - NASDAQ Seeking View JAZZ Breaking News & Analysis - Seeking Alpha
Spotlight View JAZZ Annual Report - CompanySpotlight.com OTC Report View JAZZ OTC Short Report - OTCShortReport.com
TradeKing View JAZZ Fundamentals - TradeKing Charts View JAZZ SEC Filings - Bar Chart
WSJ View Historical Prices for JAZZ - The WSJ Morningstar View Performance/Total Return for JAZZ - Morningstar
MarketWatch View the Analyst Estimates for JAZZ - MarketWatch CNBC View the Earnings History for JAZZ - CNBC
StockMarketWatch View the JAZZ Earnings - StockMarketWatch MacroAxis View JAZZ Buy or Sell Recommendations - MacroAxis
Bullish View the JAZZ Bullish Patterns - American Bulls Short Pains View JAZZ Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View JAZZ Stock Mentions - StockTwits PennyStocks View JAZZ Stock Mentions - PennyStockTweets
Twitter View JAZZ Stock Mentions - Twitter Invest Hub View JAZZ Investment Forum News - Investor Hub
Yahoo View JAZZ Stock Mentions - Yahoo! Message Board Seeking Alpha View JAZZ Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for JAZZ - SECform4.com Insider Cow View Insider Transactions for JAZZ - Insider Cow
CNBC View JAZZ Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for JAZZ - OTC Markets
Yahoo View Insider Transactions for JAZZ - Yahoo! Finance NASDAQ View Institutional Holdings for JAZZ - NASDAQ


Stock Charts

FinViz View JAZZ Stock Insight & Charts - FinViz.com StockCharts View JAZZ Investment Charts - StockCharts.com
BarChart View JAZZ Stock Overview & Charts - BarChart Trading View View JAZZ User Generated Charts - Trading View




Latest Financial News for JAZZ


The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering
Posted on Thursday March 21, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 20) AstraZeneca plc (NYSE: AZN ) BioDelivery Sciences ...


FDA approves Jazz Pharmaceuticals sleep disorder drug
Posted on Wednesday March 20, 2019

The Food and Drug Administration approved Jazz Pharmaceuticals' new drug application for Sunosi, a once-daily medicine designed to improve wakefulness in adult patients suffering from narcolepsy and obstructive sleep apnea. Sunosi is expected to be commercially available in the United States following the final scheduling decision by the U.S. Drug Enforcement Administration, which is typically rendered within 90 days of FDA approval. Jazz Pharmaceuticals, which is based in Dublin, Ireland, has major operations in Philadelphia where the company has about 160 employees.


Jazz Pharma's sleep disorder treatment gets FDA nod
Posted on Wednesday March 20, 2019

The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's treatment for patients with a form of sleep disorder, the company said on Wednesday. The drug, solriamfetol, will treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea (OSA). Solriamfetol is expected to be commercially available in the United States following the final scheduling decision by the Drug Enforcement Administration (DEA), Jazz said in a statement.


Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi™ (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
Posted on Wednesday March 20, 2019

DUBLIN, March 20, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved Sunosi™ (solriamfetol) to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA). Once-daily Sunosi is approved with doses of 75 mg and 150 mg for patients with narcolepsy and doses of 37.5 mg, 75 mg, and 150 mg for patients with OSA.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.